January 1, 2008


Drug Approvals, Shortages, Recalls, Adverse Events


IDSA offers a members-only service that e-mails ID-related messages from the Food and Drug Administration on label changes, adverse events, newly approved drugs and other safety information on FDA-approved drugs and biologics.  Recent alerts included:

To sign up for this service IDSA members can visit: http://www.idsociety.org/Content.aspx?id=4250.

< Previous Article | Next Article >

Adult and Adolescent HIV Treatment Guidelines Updated
IDSA Publishes Updated Guidelines on Aspergillus
CDC Releases Updated Immunization Schedule
Drug Approvals, Shortages, Recalls, Adverse Events
EIN Reports Problems with Vancomycin Levels
In the IDSA Journals
Outbreaks and Bioemergencies
Developing a Research Agenda for HIV and Aging
First Annual IDSA Fellows’ In-Training Exam June 3 and 4
New Resources for State and Regional Societies
CDC Finds Low Rates of Adult Immunization
IDSA Advocacy Update
New Law Requires Free Access to NIH-funded Research
Members on the Move
Welcome, New IDSA Members!
WHO Promotes Community Health Workers for HIV/AIDS Care
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA